SINGAPORE, Nov. 5, 2024 /PRNewswire/ -- ICP Hub Singapore, funded and supported by the DFINITY Foundation, the creator of Internet Computer Protocol (ICP), is proud to announce its prominent showcase at the Singapore Fintech Festival. Located in Hall 4, directly opposite the Talent Stage, ICP Hub Singapore's booth will offer an immersive experience themed "Innovate Securely, Comply Globally, Impact Sustainably." In collaboration with the United Nations Development Programme (UNDP) and the Global Fintech Institute (GFI), the hub will highlight groundbreaking blockchain solutions that prioritize security, regulatory compliance, and sustainable social impact.
Empowering Sustainable Development Through Blockchain
A key feature of this year's exhibit is ICP Hub Singapore's collaboration with UNDP to present blockchain projects that advance sustainable development goals. These initiatives emphasize transparency, inclusivity, and secure digital solutions aligned with UNDP's mission of achieving the Sustainable Development Goals (SDGs). Notably, the Universal Trusted Credentials (UTC) initiative leverages ICP technology to create trusted, tamper-proof systems that enable transparent and efficient service delivery worldwide. Attendees will gain insight into how blockchain can foster social and economic impact, supporting sustainable development across diverse communities.
Promoting Compliance and Financial Literacy with the Global Fintech Institute
In partnership with GFI, ICP Hub Singapore will showcase how blockchain technology supports responsible and compliant innovation in finance. GFI, an institution dedicated to financial literacy and ethical standards in fintech, brings its regulatory expertise and global compliance focus to the partnership. At the booth, GFI experts will lead sessions on navigating blockchain regulations, providing insights into how secure, compliant solutions can drive responsible fintech adoption globally. These sessions underscore the value of integrating compliance and transparency into digital financial ecosystems.
Innovate Securely, Comply Globally, Impact Sustainably
Under the theme "Innovate Securely, Comply Globally, Impact Sustainably," ICP Hub Singapore, UNDP, and GFI aim to create a collaborative platform for exploring blockchain's transformative potential while ensuring adherence to high standards of security, compliance, and social responsibility. Through live demonstrations, hands-on workshops, and expert panels, visitors will discover how ICP technology facilitates scalable, compliant solutions that meet local and global regulatory needs, paving the way for secure and impactful innovations.
Meet Us at Hall 4, Opposite the Talent Stage
Attendees of the Singapore Fintech Festival are invited to visit ICP Hub Singapore's booth in Hall 4 for an in-depth look at how blockchain technology can revolutionize industries while upholding standards of security, compliance, and sustainability. Experience firsthand how ICP Hub Singapore, with the support of the DFINITY Foundation, UNDP, and GFI, is empowering communities, enhancing transparency, and setting benchmarks for sustainable fintech solutions.
About ICP Hub Singapore
ICP Hub Singapore is dedicated to accelerating blockchain adoption and ecosystem growth through partnerships, education, and community-building. Supported by the DFINITY Foundation, the creator of Internet Computer Protocol (ICP), ICP Hub Singapore works with academic institutions, government bodies, and industry leaders to promote decentralized technology that drives economic development and social progress.
About the United Nations Development Programme (UNDP)
The United Nations Development Programme (UNDP) is the United Nations' global development network, advocating for change and connecting countries to resources that help build better lives. Working across 170 countries and territories, UNDP aims to eradicate poverty, reduce inequalities, and foster resilience. In partnership with ICP Hub Singapore, UNDP is advancing sustainable development through blockchain initiatives that enhance transparency, inclusion, and trust in financial and social systems.
About the Global Fintech Institute (GFI)
The Global Fintech Institute (GFI) is a non-profit organization dedicated to fostering the development of secure, inclusive, and compliant fintech solutions. GFI emphasizes financial literacy, professional standards, and regulatory alignment, supporting fintech practitioners, regulators, and policymakers globally. Through its collaboration with ICP Hub Singapore, GFI is committed to empowering communities with compliant and secure financial technologies that drive the future of finance.
For more information, visit our booth in Hall 4 or contact us at www.icphubsg.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
ICP Hub Singapore Showcases 'Innovate Securely, Comply Globally, Impact Sustainably' at Singapore Fintech Festival with Partners UNDP and Global Fintech Institute
- Yuhan Corporation CEO Wook Je Cho, National Assembly Member Seong Hoon Park, and KAIST Professor Joung Ho Kim join a pioneering collaboration in precision oncology.
SEOUL, South Korea, Nov. 5, 2024 /PRNewswire/ -- On November 4, 2024, J INTS BIO hosted a significant MOU signing ceremony at Baekyangnuri Plaza, Yonsei University, unveiling a groundbreaking AI-driven collaboration to revolutionize cancer treatment. This ambitious alliance unites leading institutions, including Yonsei University College of Medicine's DAAN Cancer Research Institute, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Korea Research Institute of Chemical Technology (KRICT), and KAIST. The event featured a distinguished lineup, with Yuhan Corporation CEO Wook Je Cho, National Assembly Representative Seong Hoon Park, and KAIST's Professor Joung Ho Kim, a prominent member of the National AI Committee, highlighting the extensive support from both government and industry sectors.
Precision Medicine Redefined: AI Meets Multi-Omics
J INTS BIO is at the forefront of developing personalized lung cancer therapies through the integration of artificial intelligence and multi-omics technology. Multi-omics offers a comprehensive approach to disease biology by combining genomics, transcriptomics, metabolomics, and proteomics. Using AI and national supercomputing infrastructure, the project aims to enhance drug efficacy prediction and minimize toxicity, addressing the critical challenges that plague conventional oncology drug development.
Professor Byoung Chul Cho of Severance Hospital, a key figure behind the development of the highly successful lung cancer drug "Leclaza," emphasized, "AI is revolutionizing precision medicine. By employing AI and supercomputing, we can achieve ultra-precise analysis of patient tissue and genetic profiles, enabling the design of highly effective, personalized treatment strategies." KAIST's Professor Joung Ho Kim added, "AI's capacity to process immense biological datasets and apply machine learning for patient-specific predictions can drastically reduce clinical trial failure rates and accelerate the entire drug discovery process."
End-to-End Research Strategy: From Biopsies to AI-Optimized Therapies
The collaboration is structured around a comprehensive, four-phase research strategy: meticulous patient sample collection and preparation, AI-driven protein analysis using supercomputers, synthesis of drug candidates informed by AI insights, and rigorous clinical trials for validation.
The DAAN Cancer Research Institute at Yonsei University will lead the first phase, collecting lung cancer tissue and genomic samples and preparing them for AI model development. Using cell and animal models, the institute will validate AI predictions, identify drug resistance mechanisms, and refine algorithms to maximize accuracy.
DGIST's Core Protein Resources Center will utilize national supercomputers to simulate protein-drug interactions, conducting high-precision structural analyses and virtual experiments. This work will confirm AI-driven hypotheses and facilitate the design of drugs tailored to the molecular characteristics of cancer.
KRICT's Medicinal Bio Research Division will synthesize the AI-recommended drug candidates, subjecting them to thorough pharmacological and toxicological assessments. KRICT Director Kwang Rok Kim remarked, "AI is fundamentally transforming the landscape of drug discovery. It allows us to develop optimized therapeutic compounds faster and with greater safety, delivering unprecedented precision in medicine."
J INTS BIO will oversee the entire project, managing clinical trials to validate AI-based predictions and develop clinically proven, patient-specific treatment protocols. This approach aims to expedite the path from laboratory research to market readiness, making advanced cancer therapies more accessible to patients worldwide.
A Game-Changer in Oncology: Government and Industry in Harmony
This collaboration marks a transformative leap in cancer research, showcasing the potential of merging AI with biotechnology. Seong-Kyoon Choi, Director of DGIST's Core Protein Resources Center, stated, "AI and supercomputing together set a new standard for protein analysis and drug design precision. This partnership is poised to deliver groundbreaking advancements in cancer treatment." National Assembly Member Seong Hoon Park underscored the national importance of this initiative: "The integration of AI and biotech is crucial for elevating South Korea's global competitiveness in the bio-industry. The government will continue to provide unwavering support for these pioneering research efforts."
Envisioning a future shaped by precision medicine, J INTS BIO and its partners aim to build extensive cancer data infrastructures, providing a solid foundation for ongoing research and innovation. The consortium plans to unveil interim results from the "AI-Supercomputing-Based Personalized Lung Cancer Therapy" project at a major international conference in the first half of next year, showcasing the project's far-reaching impact and potential.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
J INTS BIO Launches AI-Supercomputing Alliance to Transform Cancer Therapy
